95 related articles for article (PubMed ID: 20540417)
1. A review of bioactive materials and chronic wounds.
Plotner AN; Mostow EN
Cutis; 2010 May; 85(5):259-66. PubMed ID: 20540417
[TBL] [Abstract][Full Text] [Related]
2. Regenerative materials that facilitate wound healing.
Mulder G; Wallin K; Tenenhaus M
Clin Plast Surg; 2012 Jul; 39(3):249-67. PubMed ID: 22732374
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of healing metrics associated with commonly used advanced wound care products for the treatment of chronic diabetic foot ulcers.
Fetterolf DE; Istwan NB; Stanziano GJ
Manag Care; 2014 Jul; 23(7):31-8. PubMed ID: 25199368
[No Abstract] [Full Text] [Related]
4. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers.
Cavorsi J; Vicari F; Wirthlin DJ; Ennis W; Kirsner R; O'Connell SM; Steinberg J; Falanga V
Wound Repair Regen; 2006; 14(2):102-9. PubMed ID: 16630097
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous tissue engineering and lower extremity wounds (part 2).
Dini V; Romanelli M; Piaggesi A; Stefani A; Mosca F
Int J Low Extrem Wounds; 2006 Mar; 5(1):27-34. PubMed ID: 16543210
[TBL] [Abstract][Full Text] [Related]
6. Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes.
Barber C; Watt A; Pham C; Humphreys K; Penington A; Mutimer K; Edwards M; Maddern G
J Wound Care; 2008 Dec; 17(12):517-27. PubMed ID: 19052516
[TBL] [Abstract][Full Text] [Related]
7. Modeling the effects of treating diabetic wounds with engineered skin substitutes.
Waugh HV; Sherratt JA
Wound Repair Regen; 2007; 15(4):556-65. PubMed ID: 17650100
[TBL] [Abstract][Full Text] [Related]
8. Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers.
Yonezawa M; Tanizaki H; Inoguchi N; Ishida M; Katoh M; Tachibana T; Miyachi Y; Kubo K; Kuroyanagi Y
Int J Dermatol; 2007 Jan; 46(1):36-42. PubMed ID: 17214717
[TBL] [Abstract][Full Text] [Related]
9. Utilization of living bilayered cell therapy (Apligraf) for heel ulcers.
Karr J
Adv Skin Wound Care; 2008 Jun; 21(6):270-4. PubMed ID: 18525250
[TBL] [Abstract][Full Text] [Related]
10. Autologous full-thickness skin substitute for healing chronic wounds.
Gibbs S; van den Hoogenband HM; Kirtschig G; Richters CD; Spiekstra SW; Breetveld M; Scheper RJ; de Boer EM
Br J Dermatol; 2006 Aug; 155(2):267-74. PubMed ID: 16882162
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based management of common chronic lower extremity ulcers.
Richmond NA; Maderal AD; Vivas AC
Dermatol Ther; 2013; 26(3):187-96. PubMed ID: 23742279
[TBL] [Abstract][Full Text] [Related]
12. Frequency rhythmic electrical modulation system in the treatment of chronic painful leg ulcers.
Janković A; Binić I
Arch Dermatol Res; 2008 Aug; 300(7):377-83. PubMed ID: 18629524
[TBL] [Abstract][Full Text] [Related]
13. Leg ulcers.
Paquette D; Falanga V
Clin Geriatr Med; 2002 Feb; 18(1):77-88, vi. PubMed ID: 11913740
[TBL] [Abstract][Full Text] [Related]
14. Apligraf--a living human skin equivalent for the treatment of chronic wounds.
Streit M; Braathen LR
Int J Artif Organs; 2000 Dec; 23(12):831-3. PubMed ID: 11197742
[TBL] [Abstract][Full Text] [Related]
15. [Human amniotic membrane in the management of chronic venous leg ulcers].
Tauzin H; Humbert P; Viennet C; Saas P; Muret P
Ann Dermatol Venereol; 2011; 138(8-9):572-9. PubMed ID: 21893230
[TBL] [Abstract][Full Text] [Related]
16. The use of pulsed radio frequency energy therapy in treating lower extremity wounds: results of a retrospective study of a wound registry.
Frykberg RG; Driver VR; Lavery LA; Armstrong DG; Isenberg RA
Ostomy Wound Manage; 2011 Mar; 57(3):22-9. PubMed ID: 21422480
[TBL] [Abstract][Full Text] [Related]
17. Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers.
Saap LJ; Donohue K; Falanga V
Dermatol Surg; 2004 Aug; 30(8):1095-100. PubMed ID: 15274699
[TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory, atypical lower extremity ulcers with tissue-engineered skin (Apligraf).
Long RE; Falabella AF; Valencia I; Eaglstein WH; Kirsner RS
Arch Dermatol; 2001 Dec; 137(12):1660-1. PubMed ID: 11735729
[No Abstract] [Full Text] [Related]
19. The use of advanced biological and tissue-engineered wound products.
Collier M
Nurs Stand; 2006 Oct 25-31; 21(7):68, 70, 72 passim. PubMed ID: 17087417
[TBL] [Abstract][Full Text] [Related]
20. Persistence of bilayered living-cell therapy donor DNA 10 months after application: a case report.
Serena TE; Bialas P
Ostomy Wound Manage; 2009 Oct; 55(10):18-22. PubMed ID: 19864692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
